Roughly 1 in 8 US adults have taken GLP-1 drugs like Wegovy, poll…
(Reuters) - About one in eight adults have taken a drug belonging to the GLP-1 class of…
(Reuters) - About one in eight adults have taken a drug belonging to the GLP-1 class of…
By Jarrett Renshaw and Trevor Hunnicutt (Reuters) - The Biden administration is expected…
By Blake Brittain (Reuters) - Apple urged a U.S. appeals court on Friday to overturn a…
By Puyaan Singh (Reuters) -Abbott Laboratories said on Tuesday the U.S. FDA has approved…
By Dietrich Knauth NEW YORK (Reuters) - Rite Aid, one of the largest U.S. pharmacy…
(Reuters) -The U.S. Centers for Disease Control and Prevention issued an advisory on…
(Reuters) -U.S. prosecutors in Virginia are probing whether Facebook-parent Meta's…
By Patrick Wingrove and Sriparna Roy (Reuters) -The U.S. Food and Drug Administration…
(Reuters) - The U.N. agency for Palestinian refugees said some employees released into…
FRANKFURT (Reuters) -German drugmaker Bayer said on Monday that it was amending its…
Welcome, Login to your account.
Welcome, Create your new account
A password will be e-mailed to you.